News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
The EHR vendor is re-engineering its architecture to increase interoperability with genetic labs and merge genomic and pathology information at the point of care.
Illumina, LabCorp, and Providence healthcare will join the effort to collect COVID-19 patient samples in the US for immune cell receptor sequencing.
The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.
The precision medicine company also is accelerating its push into diabetes, depression, and cardiology after getting its solid-tumor test turnaround down to 9 days.
The effort is focused on building an atlas of immune cell types found across a range of Asian population groups as part of the Human Cell Atlas project.
